BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Another top option is HGH Fragment 176-191 , which stimulates fat loss and muscle gain by increasing the production of human growth hormone
PET, positron emission tomography
However, their homes and livelihoods are increasingly threatened by two factors: government-led initiatives to consolidate fragmented farmland for industrial-scale food production and real estate-driven urban village redevelopment projects, which replace affordable housing and informal markets